SCHEMBL20118222

SCHEMBL20118222

COCC1=NN(c2ccc(F)cc2Cl)C(=O)[C@]12CC[C@H](N)CC2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 4/20 0.34
OPRM1 P35372 2/20 0.34
OPRK1 P41145 2/20 0.34
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
OXTR P30559 3/20 0.32
GRM5 P41594 2/20 0.32
P2RX7 Q99572 4/20 0.31
DPP4 P27487 1/20 0.31
BACE1 P56817 2/20 0.31
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
CASP6 P55212 1/20 0.30
KMT2A Q03164 1/20 0.30
CRHR1 P34998 1/20 0.30
CRHR2 Q13324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118389 0.90 GRM5 (0.33) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118223 0.90 GRM5 (0.33) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118172 0.78 P2RX7 (0.35) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118169 0.78 P2RX7 (0.35) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118401 0.77 PSEN1 (0.37) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118185 0.76 OPRM1 (0.35) OPRL1OPRM1OPRK1P2RX7MEN1
SCHEMBL20118183 0.74 KDM4E (0.45)
SCHEMBL20118395 0.73 KMT2A (0.39) P2RX7MEN1GAACASP6KMT2A
SCHEMBL20118108 0.72 PSEN1 (0.35) OPRL1OPRM1OPRK1PSEN1PSEN2
SCHEMBL20118049 0.69 CASP6 (0.36) OPRL1OPRM1OPRK1P2RX7MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018078009-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-03 WO disclosed